LikeMinds, Inc. announced that its CEO, Peter Savas, will present at Biotech Showcase™ 2018 in San Francisco January 8–10. Mr. Savas' update will cover LikeMinds' clinical and commercial...

ViaCyte, Inc., a privately-held regenerative medicine company, today announced that the first patients have been implanted in Cohort 2 with a potentially efficacious dose of the company's...

Citius Pharmaceuticals, Inc. ("Citius") ("CTXR"), a specialty pharmaceutical company focused on adjunctive cancer care and critical care drug products, announced today that it will be presenting...

Agenus Inc. (NASDAQ: AGEN), an immuno-oncology company with a pipeline of immune checkpoint antibodies and cancer vaccines, today announced that Dr. John Castle, Head of Translational Medicine and...

CytRx Corporation (NASDAQ: CYTR), a biopharmaceutical research and development company specializing in oncology, today announced that Chairman and CEO Steven A. Kriegsman and David Haen, Vice...